NeuroVive Pharmaceutical ABの売上総利益
NeuroVive Pharmaceutical ABの売上総利益 は何ですか。
NeuroVive Pharmaceutical ABの売上総利益 は-68,572.19%です。
売上総利益 の定義は何ですか。
売上総利益は、売上と商品の売上原価との差を収益で除してパーセンテージで表したものです。
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
LSEのセクタMiscellaneousにおける売上総利益 の企業と比べるNeuroVive Pharmaceutical AB
NeuroVive Pharmaceutical ABは何をしますか。
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
NeuroVive Pharmaceutical ABと類似の売上総利益
- Evrim Resourcesの売上総利益 は-6,834,878.25%です。
- Neovacs S.Aの売上総利益 は-339,000.00%です。
- Peak Resourcesの売上総利益 は-78,111.11%です。
- NeuroVive Pharmaceutical ABの売上総利益 は-68,572.19%です。
- ProMIS Neurosciencesの売上総利益 は-60,710.44%です。
- Eco (Atlantic) Oil & Gasの売上総利益 は-54,253.94%です。
- Solarvest Bioの売上総利益 は-47,000.00%です。
- ProMIS Neurosciencesの売上総利益 は-46,300.00%です。
- Magnis Resourcesの売上総利益 は-45,793.10%です。
- Pure Mineralsの売上総利益 は-44,700.00%です。